News / 6th August 2019

Emovi CSO Dr. Alexandre Fuentes Presents “Functional Return to Duty Decision Making Post MTBI and Musculoskeletal Injury” During 2019 MHSRS

Fuentes’ poster covers the addition of an objective biomechanical assessment into the management of knee osteoarthritis for civilian patients. Montreal, Quebec (August 6, 2019) Emovi, Inc., manufacturer of the KneeKG device, today announced that Chief Science Officer, Dr. Alexandre Fuentes will present at the Military Health System Research Symposium (MHSRS), which takes place Aug 19-21,

News / 26th July 2019

New Device Pinpoints Knee Pain Sources Better in Minutes

Montreal, Canada-based Emovi, Inc. has announced the U.S. launch of KneeKG, the first in-clinic device that enables physicians to assess knees “while the patient is in motion and weight-bearing.” The machine, which pinpoints biomechanical markers known to be linked to patient’s symptoms, can provide useful data in just 15 minutes. According to the company, “KneeKG

News / 19th July 2019

An EKG for the Knee

The KneeKG evaluates knee functional deficiencies while the joint is in motion and bearing weight, providing physicians with more information about diseases or injuries than static technologies such as x-ray or MRI. Knee pain due to arthritis or injury is the second most common cause of chronic pain in the United States. Osteoarthritis affects more

News / 17th July 2019

Knee assessment device available in Canada and US

MONTREAL – Emovi, Inc. announced the U.S. launch of KneeKG, the first in-clinic device that meets the global need for measuring knee function with objective and quantifiable data associated with mechanical knee markers and functional deficiencies. KneeKG is the first device to enable doctors to accurately assess patients’ knees in 3D while the patient is

News / 16th July 2019

Emovi Announces U.S. Commercial Launch of KneeKG In-Clinic Device that Measures and Quantifies Knee Function

KneeKG is the first device to enable doctors to accurately assess patients’ knees in 3D while the patient is moving and weight-bearing Montreal, Quebec – July 16, 2019 – Emovi, Inc. today announced the U.S. launch of KneeKG™, the first in-clinic device that meets the global need for measuring knee function with objective and quantifiable

News / 11th July 2019

Emovi Announces U.S. Commercial Launch of KneeKG In-Clinic Device

KneeKG enables doctors to accurately assess patients’ knees in 3D while the patient is moving. has announced the U.S. launch of KneeKG, the first in-clinic device that meets the global need for measuring knee function with objective and quantifiable data associated with mechanical knee markers and functional deficiencies. KneeKG is the first device to enable

News / 17th April 2019

Emovi’s KneeKG adopted by Nova Scotia Health Authority to improve Knee Surgery Waiting times and Reduce Costs

Montreal, CANADA – April 17th, 2019 – The Nova Scotia Health Authority (NSHA) announced today that it is working to support the commercialization of a provincially implemented software platform and assessment tools that will improve orthopaedic wait times and patient outcomes across Nova Scotia and that Emovi’s KneeKG is a key component of the solution.

News / 4th March 2019

EMOVI IS ACCELERATING ITS GROWTH THROUGH A 15M$ SERIES C INVESTMENT LED BY TVM CAPITAL LIFE SCIENCE.

PR Financing Jan 2019 vF ENG Montreal, CANADA – March 4th, 2019 – Emovi announced today its partnership with TVM Capital Life Science and co-investors StandUp Ventures and Desjardins Capital to support its global commercial activities. This 15M$ Series C investment is combined with other capital for a total of 20M$. With this capital infusion,

News / 22nd June 2018

EMOVI RECOGNIZED AS ONE OF THE TOP MEDICAL TECHNOLOGY STARTUPS IN 2018

Emovi has been selected from over 700 applicants to participate in the MedTech Innovator 2018 Showcase Program to be recognized as one of the top startups in the MedTech industry for 2018. MedTech Innovator is recognized as one of eight accelerators in the nation by the U.S. Department of Health and Human Services to drive

News / 7th June 2018

EMOVI’S KNEEKG DEVICE ACCEPTED TO SMART HEALTH INNOVATION LAB’S CERTIFICATION PROGRAM, USA

Montréal, Canada, June 7th, 2018. – Emovi, today announced that it has been selected to participate in a unique certification program at the newly-opened Smart Health Innovation Lab, founded by Aspire Ventures, Capital BlueCross, Clio Health, and Penn Medicine Lancaster General Health. The Smart Health Innovation Lab is a program designed to help market-ready healthcare

Events

Date/Time Event
19/08/2019 - 21/08/2019
Toute la journée
Military Health System Research Symposium (MHSRS)
TBD, Kissimmee Florida
12/03/2019 - 16/03/2019
Toute la journée
AAOS annual meeting (American Academy of Orthopaedic surgeons), New Orleans, Louisiana
Orange County Convention Center, Orlando Florida
01/11/2018 - 04/11/2018
Toute la journée
American Association of Orthopaedic Executive (AAOE)
Hyatt Regency Orlando, Orlando Florida
21/05/2018 - 22/05/2018
Toute la journée
Philadelphia Health IT Summit
Sheraton Philadelphia Downtown, Philadelphia Pennsylva
02/11/2017 - 05/11/2017
Toute la journée
American Association of Hip and Knee Surgeons (AAHKS)
Hilton Anatole, Dallas Texas